Product Information

SACUBITRIL-VALSARTAN 97-103 MG is a generic product labeled by Novugen Pharma (USA) LLC, priced at $0.5932 per EA under NDC 82293002920. Its NADAC has been published 38 times since Dec 3, 2025.

FDA first approved this application on Jul 16, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SACUBITRIL-VALSARTAN 97-103 MG

Sacubitril and Valsartan
$0.5932per EA

Strength

97; 103 mg/1; mg/1

NDC

82293002920

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SACUBITRIL; VALSARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA213611

FDA Approved

7/16/2025

TE Code

AB

On Market Since

7/16/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Neprilysin Inhibitor
Neprilysin Inhibitors

Price Statistics

The NADAC for SACUBITRIL-VALSARTAN 97-103 MG has been published 38 times since Dec 3, 2025, and over the history we have for it it has declined 42.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5932 per EA
All-time high$1.0314 (Dec 10, 2025)
All-time low$0.5796 (Jul 22, 2026)
52-week high$1.0314
52-week low$0.5796
Median price$0.6627
Average price$0.7070
Largest weekly change-13.9% (Jan 21, 2026)
Weeks tracked38
Tracking sinceDec 3, 2025

Price History

1W

+2.3%

1M

+2.3%

3M

-2.5%

6M

-14.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-42.5%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SACUBITRIL-VALSARTAN 97-103 MG?

The current National Average Drug Acquisition Cost (NADAC) for SACUBITRIL-VALSARTAN 97-103 MG, manufactured by Novugen Pharma (USA) LLC, is $0.5932 per EA (NDC 82293002920), effective Aug 19, 2026.

How has the price of SACUBITRIL-VALSARTAN 97-103 MG changed over time?

Over the history we have for it, the NADAC for SACUBITRIL-VALSARTAN 97-103 MG has declined 42.5%. It has been tracked across 38 weekly CMS publications since Dec 3, 2025.

What are the highest and lowest recorded NADAC prices for SACUBITRIL-VALSARTAN 97-103 MG?

Since Dec 3, 2025, the NADAC for SACUBITRIL-VALSARTAN 97-103 MG has ranged from a low of $0.5796 (Jul 22, 2026) to a high of $1.0314 (Dec 10, 2025), with a median of $0.6627 per EA.

Are there cheaper alternatives to SACUBITRIL-VALSARTAN 97-103 MG?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SACUBITRIL-VALSARTAN 97-103 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures SACUBITRIL-VALSARTAN 97-103 MG?

SACUBITRIL-VALSARTAN 97-103 MG (NDC 82293002920) is labeled by Novugen Pharma (USA) LLC, and CMS classifies it as a generic product.